〈美股熱門股〉VIR新冠藥有望抗Omicron大漲12% Roku吞敗訴又遭看衰跌8%2021/12/16美股熱門股美股熱門股產業Vir BiotechnologyGSK新冠藥物單株抗體療法OmicronRoku侵權Universal ElectronicsUSITC活躍用戶